Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02105350
Title A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto

biliary tract cancer


Binimetinib + Gemcitabine + Oxaliplatin

Age Groups: adult
Covered Countries

No variant requirements are available.